NextCure (NXTC) News
NASDAQ: NXTCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
6.45-0.33 (-4.87%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
NXTC news summary
We found 3 recent headlines mentioning NextCure (NXTC): 2 in the past week and 3 in the past 30 days, most often from Nasdaq, GlobeNewswire. For price context, NXTC is down 4.87% at $6.45. The most recent story, "NextCure, Inc. Announces Record Date and Distribution Date for Pre-Closing Distribution of Contingent Value Rights", was published by Nasdaq on Nov 20, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest NextCure headlines
- NextCure, Inc. Announces Record Date and Distribution Date for Pre-Closing Distribution of Contingent Value RightsNextCure, Inc. announced that its board of directors determined the record date and distribution date for its previously disclosed Pre-Closing Distribution of contingent value rights. The record date…Nasdaq
- NextCure, Inc. Receives Nasdaq Non-Compliance Notice on November 16, 2026On November 16, 2026, NextCure, Inc. received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market, LLC notifying the company that it was not in compliance with the…NasdaqNXTC, BF.A
- NextCure Provides Business Update and Reports Third Quarter 2026 Financial ResultsBALTIMORE, Md., Nov. 10, 2026 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), today provided a business update and reported financial results for the third quarter ended September 30, 2026.GlobeNewswire